Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Surgery
Stricture
Tailored therapy
Epigenetics
Biologics
Consensus
Immune cells
Primary sclerosing cholangitis
Inhibitor
MARKER
Thérapie ciblée
Vedolizumab
Kidney diseases
Effectiveness
Intestinal crypts
Inflammatory Bowel Diseases
Résistance
Endoscopic treatment
Contraindication
Inclusion
Inflammatory bowel disease
IL23
Microbiote
Anti-TNF agents
Survival
Colectomy
Disability
Monitoring
Ustekinumab
MICROBIOTA
Methylation
Colorectal cancer
PCR
Patients experience
Immunosuppressant
Bactéries
18 FDG-PET/CT
IL12
Colon cancer
Maintenance therapy
Gènes
Therapeutics
RISK
Méthylation
Safety
T1118 translocation
Genes
Anti-TNF
Bacteria
Clinical trial
Patient-reported outcome
Acceptability
Disease Progression
MORTALITY
Upper gastrointestinal tract
Dysbiosis
Original Article Clinical
Eradication
Neoadjuvant chemotherapy
Colonic epithelial primary cells
Rituximab
Gene methylation
Inflammatory bowel diseases
MALT
Crohn's disease
COLON-CANCER
Ulcerative colitis
IBD
Eligibility
Gene expression
Resistance
Clinical guidelines
Fecal microbiota
Parvimonas micra
Microbiota
Disease progression
Algorithm
Venous thromboembolism
Small molecules
DNA METHYLATION
Cost effectiveness
Alkylating agents
Dysbiose
DNA methylation
Cancer
Rituximab plus chlorambucil
Helicobacter pylori
Screening
CARCINOGENESIS
Heart disease risk factors
Cell adhesion
Colorectal cancer Colibactin and lipids
Tuberculosis
Drug
Crohn’s disease
Biomarker
HIV
Over 80s
Colon
Epigénétiques
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|